Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Establishment of a Radiogenomics ConsortiumCatharine West, Barry S Rosenstein, Jan Alsner, et al.
Nature Reviews. Clinical Oncology|August 5, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Ane Appelt, Robert Glynne-Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2025
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancerCamilla Skinnerup Byskov, Hanna R Mortensen, Marie-Claude Biston, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2013
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in EuropeCornelis J H van de Velde, Cynthia Aristei, Petra G Boelens, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Radiogenomics: radiobiology enters the era of big data and team scienceBarry S Rosenstein, Catharine M West, Søren M Bentzen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectumCornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Establishment of a Radiogenomics ConsortiumCatharine West, Barry S Rosenstein, Jan Alsner, et al.
Nature Reviews. Clinical Oncology|August 5, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Ane Appelt, Robert Glynne-Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2025
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancerCamilla Skinnerup Byskov, Hanna R Mortensen, Marie-Claude Biston, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2013
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in EuropeCornelis J H van de Velde, Cynthia Aristei, Petra G Boelens, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Radiogenomics: radiobiology enters the era of big data and team scienceBarry S Rosenstein, Catharine M West, Søren M Bentzen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectumCornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Pageof 29